Bringing New Hope to Chinese Dialysis Patients with Hyperphosphatemia SHANGHAI, Feb. 26, 2025 /PRNewswire/ -- Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (Fosun Pharma; stock code: 600196.SH, 02196.HK) announced that its holding subsidiary, Shanghai Fosun Pharmaceutical Industrial...
Read More Details
Finally We wish PressBee provided you with enough information of ( Fosun Pharma Received NMPA Approval for Wan Ti Le (Tenapanor Hydrochloride Tablets) )
Also on site :
- 7 Best Ways To Style Linen Pants, According to a Celebrity Stylist
- Peter Weber Goes Public With His Relationship and His Family Has Thoughts
- 'I Tried Taylor Swift's Posture-Correcting Sports Bra—Here's My Honest Review'